H Gonzalez1, A Farbrot, O Larkö, A-M Wennberg. 1. Department of Dermatology and Venereology, Sahlgrenska University Hospital, Gröna Stråket 16, S-413 45 Göteborg, Sweden. helena.gonzalez@vgregion.se
Abstract
BACKGROUND: Benzophenone-3 (BZ-3; 2-hydroxy-4-methoxybenzophenone, oxybenzone) is commonly used to absorb ultraviolet (UV) radiation. BZ-3 penetrates the skin and can be found in the urine. The amount varies between 0.4% and 2%. This seems to be the main metabolic pathway in rats. OBJECTIVES: To investigate the total amount of BZ-3 excreted in the urine after repeated topical whole-body applications of a sunscreen and to see if UV radiation has any effect on the amount excreted. METHODS: Twenty-five volunteers applied a commercially available sunscreen containing 4% BZ-3 morning and night for 5 days. Their urine was measured during those 5 days and during a further 5 days after the last application. They were divided into groups A (unirradiated) and B. Group B received UV radiation according to skin type: UVA between 400 and 707 J cm(-2), and UVB between 0.46 and 2.0 J cm(-2). BZ-3 in urine was analysed with a high-performance liquid chromatography method. RESULTS: The volunteers excreted 1.2-8.7% (mean 3.7%) of the total amount of BZ-3 applied. There was no significant difference between the two groups (P < 0.99, t-test). CONCLUSIONS: We show that a large amount of BZ-3 is absorbed. BZ-3 is accumulated in the body as the volunteers excreted BZ-3 5 days after the last application.
BACKGROUND:Benzophenone-3 (BZ-3; 2-hydroxy-4-methoxybenzophenone, oxybenzone) is commonly used to absorb ultraviolet (UV) radiation. BZ-3 penetrates the skin and can be found in the urine. The amount varies between 0.4% and 2%. This seems to be the main metabolic pathway in rats. OBJECTIVES: To investigate the total amount of BZ-3 excreted in the urine after repeated topical whole-body applications of a sunscreen and to see if UV radiation has any effect on the amount excreted. METHODS: Twenty-five volunteers applied a commercially available sunscreen containing 4% BZ-3 morning and night for 5 days. Their urine was measured during those 5 days and during a further 5 days after the last application. They were divided into groups A (unirradiated) and B. Group B received UV radiation according to skin type: UVA between 400 and 707 J cm(-2), and UVB between 0.46 and 2.0 J cm(-2). BZ-3 in urine was analysed with a high-performance liquid chromatography method. RESULTS: The volunteers excreted 1.2-8.7% (mean 3.7%) of the total amount of BZ-3 applied. There was no significant difference between the two groups (P < 0.99, t-test). CONCLUSIONS: We show that a large amount of BZ-3 is absorbed. BZ-3 is accumulated in the body as the volunteers excreted BZ-3 5 days after the last application.
Authors: Humberto Parada; Marilie D Gammon; Hope L Ettore; Jia Chen; Antonia M Calafat; Alfred I Neugut; Regina M Santella; Mary S Wolff; Susan L Teitelbaum Journal: Environ Int Date: 2019-06-19 Impact factor: 9.621
Authors: Murali K Matta; Robbert Zusterzeel; Nageswara R Pilli; Vikram Patel; Donna A Volpe; Jeffry Florian; Luke Oh; Edward Bashaw; Issam Zineh; Carlos Sanabria; Sarah Kemp; Anthony Godfrey; Steven Adah; Sergio Coelho; Jian Wang; Lesley-Anne Furlong; Charles Ganley; Theresa Michele; David G Strauss Journal: JAMA Date: 2019-06-04 Impact factor: 56.272
Authors: Mary E Mortensen; Antonia M Calafat; Xiaoyun Ye; Lee-Yang Wong; David J Wright; James L Pirkle; Lori S Merrill; John Moye Journal: Environ Res Date: 2014-01-11 Impact factor: 6.498
Authors: Antonia M Calafat; Jennifer Weuve; Xiaoyun Ye; Lily T Jia; Howard Hu; Steven Ringer; Ken Huttner; Russ Hauser Journal: Environ Health Perspect Date: 2008-12-10 Impact factor: 9.031